Category: Whitepaper

EXCLUSIVE INSIGHTS

Advancing Injectable Drug Delivery Systems

Increase the chance of commercial success

By Clare Beddoes • Head of Drug Delivery

Featuring exclusive interviews from industry leaders and pharma innovators

Get insider insights

Tell us a bit about yourself and we’ll email the guide directly to you.


Each article provides exclusive insights on different aspects of injectable drug delivery, offering valuable perspectives on design, usability, and market trends

Expert Perspectives and Innovations

  • As more complex injectable drugs move from clinic to home, are devices keeping pace with patient expectations and healthcare system expectations?
  • What does it take to make drug delivery safer, simpler, and more effective, especially when every second counts?
  • What role does user-centered design play in making advanced therapies more accessible and effective?
  • Looking ahead, how can delivery technology help unlock access to life-changing treatments?

To answer these questions, this downloadable PDF explores the future of injectable drug delivery, spotlighting innovations that are transforming patient care. Furthermore, through real-world examples, we dive into how device design, patient-centricity, and pharma-device collaboration are reshaping the landscape.

Download the guide to access the full interviews and explore these insights in detail:

Epinephrine injectors for pediatric use
Improving usability for effective emergency treatment

Ocular drug delivery
Advancing sustained release to ease the burden of acute therapies

User-centered infusion pumps
Enhancing patient comfort and convenience

Advanced Parkinson’s Disease treatments
Strategies to overcome regulatory challenges

platform technologies|Figure 1: Platform devices are designed to support delivery of multiple formulations.|Figure 2: Example platform test plan (for each precondition) to provide confidence in the performance envelope.|Figure 3: Example bridging test plan for injection device.
Analysis
Healthcare

From platform to product: Accelerating time-to-market for platform technologies

29th January 2025
Fran Pencliffe of Cambridge Design Partnership explores the benefits of platform devices for parenteral delivery and outlines the challenges, risks and best practices when bringing a combination product to market in this way.
Read More
|||
Analysis
Drug Delivery
Healthcare

Pump It Up: User-Centered Infusion Pumps on the Rise

14th November 2024
The pharma industry’s move towards larger volumes of subcutaneous (SC) therapeutics and home-based care is increasing the demand for self-administration devices. We recently partnered with KORU to explore innovations in infusion pump technology aimed at enhancing patient comfort and convenience
Read More
Klarus-Injection-R-wide

Therapy assistant for parenteral drugs

21st April 2020
Patients suffering from chronic diseases such as rheumatoid arthritis or multiple sclerosis often follow a complicated treatment regimen at home. They sometimes need to store their drugs in the fridge, warm them up to the correct temperature for injection, prepare their auto-injector for use and finally dispose of the used device safely.
Read More
WHITEPAPER

Accurately Estimating Blood Loss

Navigating Design Challenges and Pioneering Future Solutions

BY BRIAN CHANG and MICHAEL MCKNIGHT
||CDP whitepaper - Accurately Estimating Blood Loss
web_body_Accurately-Estimating-Blood-Loss
DOWNLOAD NOW

Significant advancements in surgery, such as the emergence of surgical robotics and augmented reality (AR)-assisted instrument navigation, have revolutionized patient care. Despite these innovations, there are still critical needs that technology has yet to fully address. One such need is the accurate and easy estimation of blood loss during surgery. The lack of a comprehensive solution for real-time monitoring of blood loss poses serious risks to patient outcomes.

In this article, we will explore the challenges of estimating blood loss (EBL), evaluate the advantages and disadvantages of various novel solutions, and discuss the key factors necessary for achieving more accurate, timely, and insightful monitoring.

Contact Us

At CDP, we integrate seamlessly with your team to accelerate your project’s development.
To discuss how we can help you, get in touch.

GET IN TOUCH
INSIGHTS

Industry Insights into the Future of Respiratory Drug Delivery

By Steve Augustyn • Deputy Head of Drug Delivery

Download your copy

DD-Respiratory_Cover-web

Advances and Opportunities in Respiratory Drug Delivery

Discover the exciting possibilities on the horizon for inhalation device design with our latest resource, “Breathing New Life: Industry Insights into the Future of Respiratory Drug Delivery”.

This e-book explores recent advancements and highlights innovative strategies crucial for developing significant new treatments.

Gain expert insights on:

The potential value of through smart inhaler technology.

Shifting away from high GWP propellants.

Maintaining drug stability and delivery precision across varied respiratory conditions.

Integrating innovation with user experience and sustainability in device design.

Developing customized devices for groundbreaking clinical research.

DOWNLOAD YOUR COPY
WHITEPAPER

Download our expert guide to developing next-generation diagnostic systems:

✓ Accelerate your time to market

✓ Increase the chance of commercial success

Receive the guide in your inbox immediately.

It’ll only take a minute.

Unlock the full potential of next-generation diagnostics systems with our 16-page guide. Gain valuable insights on:

  • Developing your value proposition
  • Understand the interplay between assay, user and product workflows
  • Capturing design input early
  • Establishing a platform system architecture
  • Planning your regulatory strategy
DX-Guide_mockup_COVER-web-1

Whether it’s unlocking the potential of a groundbreaking biomarker, innovating with new assay or detection technologies, or navigating the updates needed for your system to compete with newer devices, the path ahead is undoubtedly complex.

That’s why we’ve distilled the essence of successful diagnostic systems development into this 10-minute guide – it’s your compass in the intricate world of diagnostics, highlighting critical considerations essential for turning ambitious ideas into tangible solutions.

DX-Guide_mockup_OPEN-7-8-web-1

Connect with CDP

Download our expert guide to uncover critical considerations for developing successful next-generation diagnostic systems. Gain practical insights to accelerate time to market, reduce development risk, and increase your chances of commercial success.

Get In Touch

Featured Insights

feature_insights-from-ECSMID25-2
Analysis
Healthcare
Life Sciences

Insights from ESCMID 2025: trends and future in diagnostic testing

23rd May 2025
This article, featuring insights from James Blakemore and Leigh Shelford, explores how ESCMID 2025 marked a shift from technology-led innovation to outcome-led diagnostics. Covering key themes including AMR, syndromic testing, sequencing, and AI, it highlights why usability, integration, and real-world impact are now critical to platform success.
Read More
shutterstock_768933475-1440×810-20pc-dark

– Bioprocessing

9th March 2026
Read More
|||||||||||||||||||||||||
Healthcare
Life Sciences

From prototype to PCR testing system, fast

1st December 2022
Innovation in a pandemic.
Read More
VIEW ALL
WHITE PAPER

Five approaches to improve smoking cessation outcomes and reduce tobacco harms globally

BY BEN KELSEY

Funded by the Foundation for a Smoke-Free World and in collaboration with Inter Scientific Limited

Brochure-mockup-COVER-fsfw-cessation
DOWNLOAD NOW

“We hope the learnings of this research will help efforts to reduce the eight million lives lost annually to smoking-related illnesses”

When you consider tobacco kills up to half of users who don’t quit, it is clear: change is needed quickly. When we also consider that many of the world’s smokers – particularly in LMICs – do not have access to affordable, evidence-based, smoking cessation interventions and that their availability differs from country to country, enabling tobacco cessation on a global scale and creating a tobacco-smoke-free world is a huge challenge.

The vision of the Foundation for a Smoke-Free World (FSFW) is to eliminate combustible tobacco, toxic tobacco forms, and smoking-related death and disease globally, with a specific emphasis on LMICs. Cambridge Design Partnership (CDP), a UK-based independent innovation partner, has been collaborating with FSFW to realize their vision since 2018.

We have identified five approaches that could positively impact tobacco cessation and suggested a model through which the process of cessation and harm reduction can be established. We hope the learnings of this research will help efforts to reduce the eight million lives lost annually to smoking-related illnesses.

CDP_web_Five-approaches-to-improve-smoking-cessation||||
DOWNLOAD NOW

Need help with an opportunity? Let’s talk.

We specialize in solving complex problems. Wherever you are in your journey we can seamlessly integrate into your innovation cycle, accelerate time to market and deliver competitive advantage.


WHITE PAPER

Maximizing the Value of Smart Packaging

BY CHRIS HOUGHTON
Smart-Packaging-Playbook
DOWNLOAD

“Smart packaging – technologically advanced packaging – can unlock a myriad of benefits, but it can also bring pitfalls, presenting a classic ‘should we, shouldn’t we?’ dilemma.”

Our complete Smart Packaging Playbook – of which the download below is an exclusive summary – helps clients quickly navigate opportunities and accelerate innovation across consumer, healthcare, and industrial sectors.

We’ve amassed examples that demonstrate smart packaging benefits, from recruiting, engaging, or retaining consumers and helping patients with medication, to providing cost-saving efficiencies in the supply chain.

You’ll find useful, actionable insights on:

  • Identifying the right opportunity at the right scale – just because you can, doesn’t mean you should.
  • Learning from the best – take learnings from one sector and apply them in another.
  • Selecting the right technology – sometimes, no tech is the smart play; other times, technology is the answer.
  • Finding the right supplier – your existing suppliers may not have the smart services your business needs.
Brochure_Mockup_2-smart-packaging-3

Download the whitepaper

WHITE PAPER

Developing future drug delivery systems

BY CLARE BEDDOES, AMY KING & JAMES HARMER
web_Futuring-drug-delivery-systems_cover

“This document explores the future of drug delivery systems, specifically at-home self-injection, and the way in which drugs will be packaged in the future to enhance patient experience and ensure successful clinical outcomes.”

Clare Beddoes – Principal Consultant, Drug Delivery

Here at CDP, we don’t think of the packaging as simply the container for the drug. We consider the whole delivery experience, from the device itself through to the accompanying materials such, as the instructions for use (IFU). While several factors must be considered in the selection of the right device and packaging materials for injectable drugs, including the drug rheology, how the drug is administered, and by whom and where, this document takes a high-level view of how specific consumer trends may impact the experience of self-injection devices.

In this paper, we explore:

  • The futuring methodologies needed to stretch strategic thinking
  • How consumer needs – and packaging – are changing
  • The consumerization of healthcare
  • Improving drug delivery systems that benefit the patient, the planet and the manufacturer
web_Futuring-drug-delivery-systems_pages

Download the white paper

WHITE PAPER

A Strategic Technology Roadmap for the UK In Vitro Diagnostics Industry

A major new report for industry leaders, government, and health tech companies

“The UK will be the industry nucleus for world-leading businesses, with the resources, skills and proven pathways for advancing pioneering technologies into successful data-enabled IVD solutions”

The UK in vitro diagnostics (IVD) industry has the potential to help boost UK economic growth and make the UK a global leader in the industry while improving health in the UK and for people worldwide. A new strategy, applied over the next 10 years, can see the industry transformed.

The Roadmap, researched and written by Cambridge Design Partnership, in partnership with CPI, the Association of British HealthTech Industries (ABHI), and funded by Innovate UK, defines the key technologies and strategies that can place the UK at the forefront of this industry.

web_IVD-Roadmap-brochures

Download the Roadmap


WHITE PAPER

A FemTech innovator’s guide to regulation

BY JESSICA PLATT, HEATHER CARE-SKINNER, STUART CURTIS, BEN STRUTT AND MARTHA HODGSON
A FemTech innovator's guide to regulation|

“Failure to adhere to regulation can cause brilliant products to fail at the last hurdle, miss a launch window, or lose money – and a health- or lifestyle-enhancing design opportunity – through clumsy remedial engineering.”

Searching for a ‘period tracker’ on the Google Play store returns almost two hundred results. Hair removal devices come with companion apps to personalize treatment. Everyday items, such as tampons, may soon save lives by diagnosing disease.

Amid this wave of innovation an essential part of the design process can be overlooked: regulation.

FemTech has three attributes that make it a particular target for regulatory attention: solutions often cross the divide between the consumer and medical sectors, they increasingly deal with sensitive data, and FemTech is dominated by start-ups.

Using a range of case studies in this white paper, we highlight some of the key considerations around regulation – and show FemTech innovators how to robustly build it into the design life-cycle.

A FemTech innovator's guide to regulation|

Download the whitepaper